1.42%)
-14.97%)
Back
3 MIN READ
The cannabis sector continues to produce astonishing returns and the current rally is not showing any signs of slowing down as volume continues to remain elevated.
From Israel to Canada, the United States to Germany, cannabis stocks are on fire and we continue to monitor this moves closely.
Capitalizing on a Cannabis Revolution
Currently, 25 states and the District of Columbia have legalized medical marijuana and four states have legalized recreational marijuana.
This revolution is not just taking place in the United States. We are seeing cannabis reform taking place all around the world. During the last two years, Brazil, Mexico, Paraguay, Puerto Rico, Canada, Uruguay, Jamaica, Portugal, and the Netherlands have taken steps to legalize or decriminalize cannabis.
As decriminalization and deregulation continues to occur across the globe, new opportunities emerge for companies within the rapidly growing cannabis industry.
Early Innings of a Multi-Decade Growth Cycle
The cannabis sector is barely in the first inning of a multi-decade growth cycle and while the full business potential of legal cannabis is only now coming into focus, early indicators suggest that the size of this market is considerable.
Over the last two years, the cannabis sector has expanded into several sub-sectors and these include but are not limited to retail operations, ancillary businesses, grow solutions, agricultural technology and biotechnology.
Two cannabis stocks that have recently come into focus include:
AeroGrow International, Inc. (AERO) is a company we have been favorable on since initiating coverage on the cannabis sector. Our favorable view is based off the company’s strategic partnership with Scotts Miracle Grow (SMG), which is an indirect beneficial owner of AeroGrow.
In early August, JP Morgan recommended SMG to its clients and changed its rating to Buy from Hold because it believes Scotts’ recent hydroponics business acquisitions will pay off as legal marijuana use increases.
We continue to view AeroGrow as a takeout candidate for Scotts, which has been aggressively purchasing hydroponic business across the globe. Shares of AERO are up more than 340% this year and we recommend watching the shares for a buy opportunity on a pullback.
Earlier this week, OWC Pharmaceutical Research Corp. (OWCP), an Israeli developer of cannabinoid-based therapies, announced that it signed an agreement for $300,000 with Medmar LLC.
Under the agreement, the funds are for the development of its proprietary psoriasis cream; Medmar has exclusive rights to manufacture, produce, publicize, promote and market OWC’s products in the U.S.; and the loan is non-interest bearing and will be repaid from royalties generated by the sale of products.
OWC conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. OWC is also developing unique delivery systems for the effective delivery and dosage of medical cannabis.
OWCP is up more than 710% in the last week and trading volume has increased incrementally. Technical420 is monitoring OWCP closely following this move and we encourage signing up for our service to learn where we see shares going from here!
Become a Technical420 Premium Member by Clicking Here…
All good -- no spamming here.
Get the Latest Cannabis News & Stock Picks.
Comments